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Introduction 
Anaesthesiologists frequently encounter rare congenital 
diseases and syndromes. Osteogenesis imperfecta (OI) is 
a fibro-osseous disorder of the collagen tissue. OI is also 
known as brittle bone disease, and is a genetic disorder of 
connective tissue in which bones fracture very easily, often 
for no apparent reason. The aetiology of the disease is a 
gene defect that produces very little or poor quality type 
1 collagen, an important building block of bones.1 Usually, 
patients inherit the disease from a parent, but sometimes 
cases are sporadic and the result of new genetic mutation.2
Other clinical features of the disease include blue sclerae, 
progressive deafness, brittle teeth (dentinogenesis 
imperfecta) and hypermobile joints. In the severe form of 
the disease, kyphoscoliosis may lead to significant chest 
wall deformity and restrictive lung disease. These two 
pathological conditions, together with recurrent pneumonia, 
can progress to cardiac failure.3 The central nervous 
system may be involved, with spinal cord or brainstem 
pressure effects, like basilar invagination or impression and 
craniovertebral junction problems.4
The incidence is 6-7 per 100 000 people, leading to defects 
in skeletal growth.5 These patients present with short 
stature and are challenging to anaesthesiologists because 
of the multi-system organ involvement of OI. Most notably, 
anaesthesiologists are challenged by a difficult airway, the 
fragile skeletal system during positioning, cardiovascular 
involvement, coagulation abnormalities and an association 
with malignant hyperthermia.2 
The diversity of presentation means that patients with severe 
forms may present with multiple fractures with minimal or 
no trauma, and persons with mild forms may only manifest 
with premature osteoporosis or severe postmenopausal 
bone mineral loss.6 There is no cure for the disease, and 
currently medical management remains symptomatic. 
Intramedullary nailing of long bones remains the method of 
choice for correcting deformities and preventing fractures.7 
We report on an OI patient with a fractured shaft of femur 
who underwent internal femur fixation. The perioperative 
management of this patient is discussed and the literature 
reviewed. 
Case report
A 21-year-old female, weighing 48 kg, with a height of 
140 cm, and a history of repeated fractures since the age of 
10 years, presented to our centre after sustaining a fractured 
right femoral shaft associated with a fall (Figure 1). She was 
a known case of OI tarda. Our institution is a tertiary care 
centre that caters to the needs of the people of northern 
India. The patient’s history revealed an uneventful antenatal 
period and no delay in milestones. Past surgical history was 
suggestive of a fractured shaft of the right femur six years 
ago, for which intramedullary nailing was completed under 
general anaesthesia (Figure 2). There was no family history 
of the disease. The patient was awake and alert at the 
preoperative assessment. A general physical examination 
revealed defective dentition, a short neck, kyphoscoliosis 
and valgus deformity bowing deformities in the lower limb 
(Figure 3). There was no pallor, icterus, cyanosis, clubbing, 
lymphadenopathy or pedal oedema. Her blood pressure 
was 124/70 mmHg and her heart rate 80 beats/minute. The 
O2 saturation in the room air was 96%. The cardiac status 
and other systemic examinations of the patient were normal, 
except for the musculoskeletal examination, which revealed 
kyphoscoliosis and valgus deformity of the lower limb.
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The preoperative laboratory investigations were normal. 
The results are shown in Table I. The preoperative 
electrocardiography, echocardiography, chest X-ray and 
coagulation profile were also normal. A pulmonary function 
test was suggestive of mild restrictive disease. Airway 
examination revealed a mouth opening of 3 cm (two 
fingerbreadths), Mallampati class III score, with a short 
neck and defective dentition. Neck flexion and extension 
were limited. The patient was accepted for surgery as 
an American Society of Anesthesiologists (ASA) grade 
III patient. In view of the anticipated difficult airway and 
normal coagulation results, it was decided to proceed with 
a regional spinal anaesthetic technique. Before anaesthesia 
was conducted, a thorough preoperative examination and 
operating room preparation were completed, including the 
procurement of difficult airway equipment (a stylet, different 
sizes of face mask, different sizes of endotracheal tube, 
all sizes of laryngoscope blade, a laryngeal mask airway 
(LMA), a Proseal® LMA, a fibre-optic bronchoscope and a 
tracheostomy set).
The patient was positioned very carefully on the operation 
table to prevent a new fracture from occurring. An 18-G 
intravenous cannula was inserted on the dorsum of the 
right hand in the operation room. Standard ASA monitors, 
including electrocardiography, noninvasive blood pressure 
monitor and pulse-oximetry, were placed on the patient. The 
Figure 1: Showing the patient with bow deformity of the lower 
limbs
Figure 2: An X-ray showing a previous intramedullary nail in situ 
and the fractured femur
Figure 3: An X-ray showing valgus deformity of the leg




Haemoglobin 12 gm/dl 12-14 gm/dl
Bleeding time 2 minutes, 10 seconds 3-5 minutes
Clotting time 4 minutes, 15 seconds 4-11 minutes
Blood sugar 90 mg/dl 60-100 mg/dl
Blood urea 25 mg/dl 15-40 mg/dl
Serum electrolytes Sodium: 135 meq/l 135-155 meq/l
Potassium: 3.2 meq/l 3.5-5.5 meq/l
Total leukocyte 
count
9 000/mm3 4 000-11 000/mm3
Platelet count 250 000/mm3 150 000-450 000/mm3
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baseline arterial pressure was 130/60 mmHg, the heart rate 
was 94 beats/minute, the respiratory rate was 18 breaths/
minute, and the O2 saturation on room air, 96%. 
An intravenous preload of 500 ml Ringer’s lactate was 
administered. Subarachnoid block was given in the 
sitting position in the space L3-4 with a 23-G Quincke 
spinal needle. Fentanyl (25 µg) was combined with 
1.6 ml bupivacaine heavy 0.5% to achieve the desired 
block. The level of the block was up to T10. The patient was 
positioned cautiously. All of the pressure points were well 
padded. During surgery, her vitals remained stable. Rescue 
medication was not required throughout the intraoperative 
period. The operation lasted for one hour and 45 minutes. 
Estimated blood loss was 600 ml, which was adequately 
replaced. The patient’s recovery was uneventful, as was her 
further stay in the hospital. She was discharged on the fifth 
postoperative day. Consent for her case to be reported was 
received from the patient.
Discussion
OI is a rare autosomal dominant inherited disease of 
connective tissue that affects bone, sclera and the inner 
ear.8 The underlying cause is mutation in the gene coding for 
type 1 procollagen, i.e. collagen, type I, alpha 1 (COL1A1) 
and COL1A2. It affects 6-7 of 100 000 people, and occurs 
in approximately in 1:20 000 births.5 Males and females 
are affected equally. No racial difference has been noted.5 
Initially, OI was divided into two forms: OI congenita and OI 
tarda. Fractures occur in utero, and death usually occurs 
in the perinatal period in the congenita form. Typically, the 
tarda form presents during childhood or early adolescence, 
and patients usually have a normal lifespan.4 The most 
commonly used classification of OI by Sillence et al9 
categorises it according to four clinical types, I, II, III and IV, 
based on its phenotypic manifestations and the radiographic 
appearances of the bones. The latest classification divides 
OI into nine types.6 The presentation of clinical severity 
depends upon the effect of mutation. Type I is considered 
to be the mildest form of the disease, and is compatible with 
long-term survival in adulthood. Types III-IX are moderate to 
severe forms of OI, depending on the defect in the structural 
proteins. Type II is lethal in the perinatal period and is not 
compatible with life.6
Anaesthetic management is influenced by coexisting 
orthopaedic deformities, vulnerability of fracture during 
simple positioning, platelet dysfunction, difficult intubation, 
cardiovascular abnormalities like mitral valve prolapse, a 
tendency to develop malignant hyperthermia, and rarely, 
extraskeletal manifestations.10,11 Because of abnormal 
skeletal growth, odontoaxial dislocation and hypermobile 
joints, a difficult airway must always be anticipated in these 
patients.12 Associated kyphoscoliosis with pectus carinatum 
may decrease vital capacity and chest wall compliance, 
with resulting arterial hypoxaemia due to ventilation 
perfusion mismatch.2 This can pose an increased risk under 
general anaesthetic. Succinylcholine should be avoided 
because of its potential to cause malignant hyperthermia. 
Fasciculations can also lead to fractures.13 Halothane is to 
be avoided as it may lead to malignant hyperthermia.10,11 
Bergstorm, and Rampton, Kelly, Shanahan and Ingram, 
reported several cases of malignant hyperthermia in OI 
patients.14,15 The general consensus is that many cases of 
hyperthermia in OI are not of the malignant type, but are 
the result of a hypermetabolic state instead. It has been 
suggested that hyperthermia is the result of either abnormal 
central nervous system temperature regulation or abnormal 
cellular energy metabolism.13,16 At least 50% of patients with 
OI also have an elevated serum thyroxine level, leading to 
increased O2 consumption and heat production.
5 Avoidance 
of common malignant hyperthermia-triggering drugs, 
temperature monitoring and the provision of necessary 
drugs and cooling devices should be easily available.15 The 
fragility of bones in these patients is well known. Malde, 
Jagtap, Pantvaidya and Kenkare reported a fracture shaft 
of the femur in a patient with OI which occurred during the 
transfer of the patient to the recovery room.12
The best anaesthetic technique in these patients is regional 
anaesthesia as it avoids the necessity of tracheal intubation. 
The development of perioperative hyperthermia is also less 
likely to occur with regional anaesthesia than with general 
anaesthesia, and the former facilitates detection of a thyroid 
storm.17 However, before administration of a regional 
anaesthetic, a coagulation profile must be undertaken 
because of the associated increase in bleeding time, 
despite the normal platelet count.2 Chances of bone injury 
during positioning should be kept in mind.
Automated blood pressure cuffs may be hazardous as 
overinflation may result in a fracture.17 Pressure points should 
be padded during prolonged surgery, and transportation 
must be gentle to prevent fracture occurrence.12
There have been several successful case reports of 
surgery being conducted under general, as well as regional 
anaesthesia on patients with OI.1,2,12 Karabiyik, Parpucu 
and Kurtipek recommended total intravenous anaesthesia 
together with an intubating LMA to manage cases electively, 
while Malde, Jagtap, Pantvaidya and Kenkare successfully 
used balanced general anaesthesia in a case of OI with 
gross deformity of the pelvis for abdominal hysterectomy.1,12
We selected to use a regional anaesthetic technique 
since the patient had to undergo lower limb surgery and 
we wanted to avoid risks and complications relating to a 
general anaesthetic. Preanaesthetic investigations included 
routine investigations and a laboratory assessment of the 
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coagulation profile to eliminate a bleeding disorder, and a full 
cardiorespiratory work-up, including electrocardiography, 
echocardiography and pulmonary function tests, to discard 
associated abnormalities that are commonly associated 
with OI. General anaesthesia was avoided because of an 
anticipated difficult airway and associated restrictive lung 
disease, as well as susceptibility to malignant hyperthermia. 
A successful outcome was ensured by taking a careful 
history and an examination, and the application of basic 
principles in the management of the case.
To conclude, patients with OI pose a significant challenge to 
the anaesthesiologist owing to a difficult airway, problems 
with positioning, susceptibility to fractures, a tendency to 
develop perioperative hyperthermia, platelet functional 
abnormalities and difficult spinal anaesthesia. A detailed 
preoperative work-up, by taking a careful history and 
examination, as well as prompt management, can improve 
the outcome in these patients.
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